Clinical Trial Update: Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cebranopadol for efficacy and safety in diabetic neuropathic pain; results completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy
• Pain

Drugs mentioned

• Cebranopadol (cebranopadol)

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: Chronic Pain, Diabetic Neuropathies | Phase 2 | Status: COMPLETED | Results posted: 2019-12-26